The Net Margin of Eris Lifesciences Ltd (ERIS.NS) is 12.16%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-03-31 | 12.16% |
| 2024-03-31 | 19.51% |
| 2023-03-31 | 22.68% |
| 2022-03-31 | 30.15% |
| 2021-03-31 | 29.30% |
| 2020-03-31 | 27.60% |
| 2019-03-31 | 29.61% |
| 2018-03-31 | 34.37% |
| 2017-03-31 | 32.93% |
| 2016-03-31 | 18.64% |